Lucius Partners Portfolio Company Voltron Therapeutics Announces Robust Immunogenicity Data: Key Prostate Cancer Target

Self Assembling Vaccine targets Prostate Stem Cell Antigen Vaccine induces immunity against an immunogenic protein; expands platform’s potential targets

NEW YORK, NEW YORK, UNITED STATES, September 6, 2023/EINPresswire.com/ — Voltron Therapeutics, […]